Among patients with high-risk prostate cancer and no evidence of metastatic disease on conventional imaging, prostate ...

Russell W. Jenkins, MD, Ph.D., a physician investigator in the Krantz Family Center for Cancer Research at the Mass General ...

Morgan Stanley (NYSE:MS) analysts have upgraded Vir Biotechnology (NASDAQ:VIR) to an "overweight" rating, shifting from ...

ARKANSAS, USA — UAMS has received a five-year, $2.9 million research grant from the National Institutes of Health based on a ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs, that ...

CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...

Oral vaccines encounter several challenges, here research explore developing and testing dmLT and saponin combination ...

The largest documented outbreak of blastomycosis in the United States was reported at a paper mill in Michigan in 2022-2023.

The advent of immunotherapy based on immune checkpoint inhibitors has improved the treatment of advanced hepatocellular ...

DIOSynVax, a clinical-stage biotechnology company at the forefront of developing innovative, broadly protective vaccines, built on the safety demonstrated by its ...